clarithromycin has been researched along with Erythema in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azzawi, S; Hoang, MP; Smith, GP | 1 |
| Choi, G; Lee, H; Shin, J; Song, H | 1 |
| LingHao, Q; Wei, L | 1 |
| Manara, GC; Pavesi, A; Torresani, C | 1 |
| Herr, H; You, CH | 1 |
2 trial(s) available for clarithromycin and Erythema
| Article | Year |
|---|---|
Clarithromycin versus doxycycline in the treatment of rosacea.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Tolerance; Erythema; Female; Humans; Italy; Male; Middle Aged; Multivariate Analysis; Rosacea; Skin Diseases; Telangiectasis; Treatment Outcome | 1997 |
Relationship between Helicobacter pylori and rosacea: it may be a myth.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Cohort Studies; Erythema; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prevalence; Rosacea | 2000 |
3 other study(ies) available for clarithromycin and Erythema
| Article | Year |
|---|---|
New onset erythematous nodules in an elderly woman.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Erythema; Fatigue; Female; Humans; Linezolid; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Tuberculosis, Cutaneous; Weight Loss | 2018 |
Cutaneous nontuberculous mycobacterial infection: a clinicopathological study of 7 cases.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Eosinophilia; Erythema; Female; Granuloma; Humans; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Skin; Skin Diseases, Bacterial; Treatment Outcome; Young Adult | 2009 |
Formulation and evaluation of less-painful clarithromycin lipid microspheres.
Topics: Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Drug Carriers; Drug Compounding; Drug Stability; Erythema; Infusions, Intravenous; Injections, Intravenous; Lipids; Microspheres; Pain; Pain Measurement; Particle Size; Rabbits; Rats; Rats, Wistar; Skin Irritancy Tests; Surface Properties | 2007 |